Cardiology Newswire
1 - Cordis Corporation Announces Agreement with Boston Scientific to Settle Selected Stent Litigation Cases
BRIDGEWATER, N.J.-(Business Wire)-September 29, 2009 - Cordis Corporation (“Cordis”) announced today that it has reached an agreement with Boston Scientific (“Boston”) resolving its Palmaz infringement suit relating to Boston’s NIR stent, settling several other cardiology-related cases...
2 - Celera to Webcast Presentation at JMP Securities 2009 Healthcare Conference
ALAMEDA, Calif.-(Business Wire)-September 29, 2009 - Celera Corporation (NASDAQ:CRA) announced today that it will webcast its presentation at the JMP Securities 2009 Healthcare conference on Tuesday, October 6, 2009. The live webcast is scheduled to begin at 10:00 am ET. Ugo DeBlasi, Chief Financial...
3 - Clinical Data, Inc. to Present at the JMP Securities Healthcare Focus Conference
NEWTON, Mass.-(Business Wire)-September 29, 2009 - Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the Fourth Annual JMP Securities Healthcare Focus Conference. Clinical Data's presentation...
4 - Court Rules in Favor of Bard in Class Action Lawsuit
MURRAY HILL, N.J.-(Business Wire)-September 29, 2009 - C. R. Bard, Inc. (NYSE: BCR) today announced that the U.S. District Court, Eastern District of Missouri, has granted Bard's summary judgment motion and dismissed with prejudice all counts in the previously-disclosed class action lawsuit entitled...
5 - PolyMedix Initiates Dosing in Phase 1B Clinical Study of Novel Anticoagulant Antagonist Compound
RADNOR, Pa.-(Business Wire)-September 29, 2009 - PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has initiated dosing and commenced a...
6 - Impulse Monitoring to Provide Neuromonitoring Support to Vanderbilt University Medical Center
COLUMBIA, Md.-(Business Wire)-September 29, 2009 - Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiological monitoring (IONM) services to hospitals, today announced that it has signed an agreement with the Vanderbilt University Medical Center (VUMC), Nashville, TN...
7 - Computable Genomix Announces Contest For Genomics Researchers
MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool. Publish or Perish will award a $10,000 grant to each...
8 - Spectranetics Submits 510(k) Application to Food and Drug Administration Seeking Clearance for the Treatment of In-Stent Restenosis in the Legs
COLORADO SPRINGS, Colo.-(Business Wire)-September 29, 2009 - Spectranetics Corporation (Nasdaq: SPNC) today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially...
9 - Flexible Stenting Solutions, Inc. Receives Conditional IDE Approval for FlexStent® Femoropopliteal Self Expanding Stent System
EATONTOWN, N.J.-(Business Wire)-September 28, 2009 - Flexible Stenting Solutions Inc. (“FSS”), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent...
10 - MedAire Offers Free Cholesterol Tests to NBAA Attendees at Booth #775
ORLANDO, Fla.-(Business Wire)-September 28, 2009 - For the 19th consecutive year, MedAire (booth 775) will offer free cholesterol screening to attendees of the 62nd Annual National Business Aviation Association (NBAA) Meeting and Convention. Test results, which are available within approximately...
11 - Positron Exhibits at the American Society of Nuclear Cardiology Annual Conference to Promote Their Cardiac Optimized Pet Scanner
INDIANAPOLIS-(Business Wire)-September 28, 2009 - Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend the 14th Annual American Society of Nuclear Cardiology (ASNC) annual conference in Minneapolis, Minnesota October 1-4, 2009 to showcase...
12 - Research and Markets: Cardiovascular Imaging 1st Edition Is Intended For Use by Clinical Cardiologists, Cardiologists in Training, Radiologists and Nuclear Physicians
DUBLIN-(Business Wire)-September 28, 2009 - Research and Markets has announced the addition of the "Cardiovascular Imaging, 1st Edition" report to their offering. In Cardiovascular Imaging the authors deal systematically with the main imaging techniques available to clinical cardiologists: nuclear...
13 - CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
WINCHESTER, Mass.-(Business Wire)-September 28, 2009 - Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), announced today that successful results...
14 - PolyMedix Receives U.S. Patent Protection for Licensed Computational Methods to Design Antimicrobial Polymers
RADNOR, Pa.-(Business Wire)-September 28, 2009 - PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for...
15 - Positron Anticipates Cardiac PET Demand to Increase Due to Expanding Reimbursment Differential Between PET and SPECT Imaging
INDIANAPOLIS-(Business Wire)-September 25, 2009 - Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, predicts a significant rise in demand for Cardiac PET in 2010 with a proposed cut in SPECT reimbursement of 46% and an increase in PET...
16 - AED Plus Save of 16-Year-Old Football Player in Minnesota Underscores the Importance of Having AEDs in Schools and at Sports Events
CHELMSFORD, Mass.-(Business Wire)-September 24, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, and the Sudden Cardiac Arrest Foundation today are jointly issuing a reminder in conjunction with SCA Awareness Month in...
17 - Reverse Medical Corporation Receives FDA IDE Clinical Study Approval for the ReStoreTM Microcatheter
IRVINE, Calif.-(Business Wire)-September 24, 2009 - Reverse Medical Corporation announced today that it has received US Food and Drug Administration (FDA) conditional approval to begin a neurothrombectomy IDE study for its ReStore™ Microcatheter at twenty US centers. The study is planned to...
18 - NEVO™ Sirolimus-Eluting Coronary Stent Associated with Significantly Less Chest Pain at Six Months Than Taxus® Liberte® Stent
SAN FRANCISCO-(Business Wire)-September 24, 2009 - At six months, patients receiving the NEVO™ Sirolimus-eluting Coronary Stent reported significantly less chest pain (also known as angina) than those receiving the Taxus® Liberte® Stent. Patients also reported improvements in their overall...
19 - Tryton Medical, Inc. Broadcasts Successful Live Case Using Company’s Side-Branch Stent™ to Definitively Treat Bifurcation Lesions at TCT 2009
DURHAM, N.C. & SAN FRANCISCO-(Business Wire)-September 24, 2009 - Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today the transmission of a live satellite feed of a clinical case performed in the United Kingdom to an...
20 - A-Life Medical, Inc. to Exhibit at the American College of Emergency Physician (ACEP) Scientific Assembly
WHO: A-Life Medical, Inc., the pioneer in and leading provider of computer-assisted coding (CAC) products and services for the healthcare industry. WHAT: A-Life Medical to Showcase its CAC Capabilities to the Emergency Medicine Marketplace at leading industry trade association platform...
21 - Dr. Danny Bluestein Joins MicroMed Science Advisory Board
HOUSTON-(Business Wire)-September 24, 2009 - On Sept. 24, MicroMed Cardiovascular (www.micromedcv.com) announced that Danny Bluestein, PhD, Professor of Bioengineering at SUNY-Stony Brook, has joined the Science Advisory Board (SAB) to provide industry expertise and guidance for the HeartAssist 5...
22 - Research and Markets: Who's Developing What in Cardiovascular Devices? - Who's Best Placed to Survive the Credit Crunch?
DUBLIN-(Business Wire)-September 24, 2009 - Research and Markets has announced the addition of the "Who's Developing What in Cardiovascular Devices?" report to their offering. The recession has caused many companies to reconsider their corporate strategy and research outlook. With the financial...
23 - Cambridge Heart Announces New Research and Development Initiative
TEWKSBURY, Mass.-(Business Wire)-September 23, 2009 - Cambridge Heart, Inc. (OTCBB-CAMH) announced today that it intends to pursue research and development efforts on a new application derived from its core Microvolt T-Wave Alternans (MTWA) technology. The Company has gathered data, which although...
24 - FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents
ST. PAUL, Minn.-(Business Wire)-September 23, 2009 - St. Jude Medical, Inc. (NYSE:STJ) today announced that the two-year results from the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial demonstrated the durability of the improved outcomes noted at...
25 - BioPharm America™ 2009 in San Francisco Sets New Benchmark for Partnering Productivity in the US
CARLSBAD, Calif. & SAN FRANCISCO-(Business Wire)-September 23, 2009 - Over 700 leaders from the biotechnology and pharmaceutical industry gathered last week for the 2nd annual BioPharm America™ partnering conference, which saw delegates from 665 companies engage in 1579 one-to-one partnering...
26 - Cook Medical’s Advanced NavAlign™ Delivery System for IVC Filters Adds Procedural Speed, Control and Accuracy
SAN FRANCISCO-(Business Wire)-September 23, 2009 - Physicians can now navigate even the most tortuous anatomy with greater speed and safety with the next-generation inferior vena cava (IVC) filter delivery system introduced today by Cook Medical at TCT 2009. The release of the NavAlign™ delivery...
27 - Celladon's MYDICAR® and Small Molecule SERCA2a Studies in Acute and Chronic Heart Failure Selected as One of Windhover’s Top 10 Cardiovascular Programs to Watch
SAN DIEGO-(Business Wire)-September 23, 2009 - Celladon Corporation today announced that its SERCA2a programs for the treatment of patients with acute and chronic heart failure have been chosen by Windhover and an independent expert panel as one of the top 10 most interesting cardiovascular projects...
28 - Two Top Heart Surgeons Join Endovalve, Inc., Scientific Advisory Board
PRINCETON, N.J.-(Business Wire)-September 23, 2009 - Endovalve, Inc., a cardiovascular device company developing the first valve-replacement system to treat mitral regurgitation, has added two top heart surgeons to its scientific advisory board (SAB), bringing the number of board members to seven...
29 - Positron Sees Global Growth in Nuclear Cardiology and Announces Pulse CDCC® Sale to Pakistan Institute
INDIANAPOLIS-(Business Wire)-September 23, 2009 - Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announces the sale of a Pulse CDCC® camera to CPE Institute Of Cardiology in Multan, Pakistan. The Pulse CDCC®, a compact digital cardiac...
30 - Abiomed Reports Results from Academic Medical Center’s Three-Year Follow-up of MACH II Trial
DANVERS, Mass.-(Business Wire)-September 23, 2009 - Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new clinical data from Academic Medical Center’s (AMC) three-year follow-up results from patients in the Impella 2.5 arm of the MACH II...
31 - Elixir Medical Corporation Announces Positive First-In-Man Results for Three Drug Eluting Coronary Stent Systems with Durable and Bioabsorbable Polymers
SUNNYVALE, Calif. & SAN FRANCISCO-(Business Wire)-September 23, 2009 - Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today positive results from three multicenter first-in-man studies of NovolimusTM...
32 - Toshiba Introduces Its Next Generation CV-3D for Infinix Cardiovascular X-ray Systems
SAN FRANCISCO-(Business Wire)-September 23, 2009 - To improve the ability of physicians to provide superior patient care during interventional procedures, Toshiba America Medical Systems, Inc. has introduced its Next Generation CV-3DTM workstation and software package available on the InfinixTM-i...
33 - Transoma Medical Enrolls First Patient in Clinical Study Comparing Use of External Recorders with Implantable Monitors to Track Recurrence of Atrial Fibrillation
ST. PAUL, Minn.-(Business Wire)-September 22, 2009 - Transoma Medical, Inc., manufacturer of Sleuth AT™, the only wireless, automated implantable cardiac monitoring system with programmable and frequent electrocardiogram (ECG) sampling, announced today the first enrollment and implant in the...
34 - Top 20 Pharma Firms to Hunt for Deals at BIO-Europe 2009
ZURICH & VIENNA-(Business Wire)-September 22, 2009 - In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 2–4 in Vienna, Austria for BIO-Europe 2009, the largest dedicated partnering conference in Europe. Teams of scouts from...
35 - Gabriel Vorobiof, MD, Named MHVI Medical Director of Non-Invasive Cardiology & Cardiac Imaging
LONG BEACH, Calif.-(Business Wire)-September 22, 2009 - Officials at Long Beach Memorial Medical Center (LBMMC) have named Gabriel Vorobiof, MD, Medical Director of Non-Invasive Cardiology and Cardiac Imaging of the MemorialCare Heart and Vascular Institute (MHVI), effective immediately. Dr...
36 - Stentys Discloses Results for World’s First Clinical Study to Treat Acute Myocardial Infarction (AMI) with a Self-Expanding Stent
PRINCETON, N.J. & PARIS-(Business Wire)-September 22, 2009 - Medical device pioneer Stentys announced today the results on 20 patients participating in the Company’s ‘APPOSITION I’ clinical study—the world’s first to treat patients with acute myocardial infarction (AMI) via a...
37 - MEDIFACTS Announces $1.9 Million Study Award with Global Pharmaceutical Company
ROCKVILLE, Md. & LANGENFELD, Germany-(Business Wire)-September 22, 2009 - MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiac diagnostic services, today announced the award of a $1.9 million contract with a Global pharmaceutical company to provide...
38 - Cardiovascular Systems Reports Two-Year Data Showing Durable Outcomes in Patients Treated with Diamondback 360° Pad System
ST. PAUL, Minn. & SAN FRANCISCO-(Business Wire)-September 22, 2009 - Two-year follow-up of patients in the first-ever prospective, multi-center clinical trial evaluating a plaque removal product show promising results after treatment with the Diamondback 360® PAD System, a minimally invasive...
39 - New Clinical Data on Medtronic Transcatheter Heart Valves Featured in More Than 25 Presentations at TCT 2009
MINNEAPOLIS-(Business Wire)-September 22, 2009 - With the promise of percutaneous treatments for patients with diseased heart valves growing, Medtronic, Inc. (NYSE: MDT), announced today that more presentations than ever before – at least 25 – on the company’s portfolio of unique transcatheter...
40 - Cambridge Heart to Exhibit, Sponsor SCA Prevention Talk at MedAxiom Conference on September 24, 2009
TEWKSBURY, Mass.-(Business Wire)-September 22, 2009 - Cambridge Heart, Inc. (OTCBB-CAMH) will exhibit its HearTwave II system and sponsor a medical education talk on sudden cardiac arrest (SCA) prevention at the Fall 2009 MedAxiom Conference. The conference will be held from September 23 to 25 in...
41 - Total Artificial Heart Manufacturer SynCardia Announces Exclusive Licensing Agreement for AorTech Polymer Heart Valve
TUCSON, Ariz.-(Business Wire)-September 22, 2009 - On Sept. 22, SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced an exclusive technology licensing agreement with AorTech International plc (AIM: AOR). This agreement...
42 - Coherex Medical Signs Exclusive Distribution Agreement with Abbott
SALT LAKE CITY-(Business Wire)-September 22, 2009 - Salt Lake City-based Coherex Medical, Inc. today announced that it has entered into a multi-year distribution agreement with global health care company Abbott for the Coherex FlatStent™ EF PFO Closure System. The Coherex FlatStent EF device is...
43 - CardiAQ Valve Technologies (CVT) Elects Serial Entrepreneur Nancy Briefs as a Director
WINCHESTER, Mass.-(Business Wire)-September 22, 2009 - CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), today announced that it has elected Nancy Briefs as a director, effective...
44 - Physio-Control Receives Market Approval from Health Canada for LIFEPAK® 15 Monitor/Defibrillator
REDMOND, Wash.-(Business Wire)-September 22, 2009 - Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., (NYSE: MDT) announced today it received approval by Health Canada to market the LIFEPAK 15 monitor/defibrillator within Canada. Official license notification was received on...
45 - Campbell’s® Healthy Request® Soups Showcase Heart-Health Benefits
CAMDEN, N.J.-(Business Wire)-September 22, 2009 - Campbell’s first heart-healthy soups have gotten a makeover just in time for soup season. The 25 varieties of Campbell’s Healthy Request soups — all of which meet the American Heart Association’s criteria to display their heart-check mark...
46 - St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis Management Solutions at Transcatheter Cardiovascular Therapeutics (TCT) 2009
ST. PAUL, Minn.-(Business Wire)-September 22, 2009 - St. Jude Medical, Inc. (NYSE:STJ) today announced it will display products and technologies from the company’s portfolio of solutions for cardiovascular healthcare professionals at the 21st annual Transcatheter Cardiovascular Therapeutics...
47 - Abiomed Presents Results from USpella; First U.S. Registry Data Evaluating 181 Patients from 16 Centers with IRB Approval
DANVERS, Mass.-(Business Wire)-September 22, 2009 - Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new clinical data from USpella, the first U.S. multicenter registry of Impella 2.5 patients evaluating the safety and feasibility of left...
48 - Midwest Ultrasound Selects Toshiba Ultrasound Products
TUSTIN, Calif.-(Business Wire)-September 22, 2009 - Midwest Ultrasound, a proven leader in providing quality cardiac and vascular ultrasound systems to a diverse client mix from small rural and community hospitals to major urban academic centers and large physician practices, entered into a two-year...
49 - Andrew Wechsler, M.D., Joins Estech as Medical Director
SAN RAMON, Calif.-(Business Wire)-September 22, 2009 - Endoscopic Technologies, Inc. (d.b.a. Estech®), a leading provider of minimally invasive cardiac surgery devices and disposables, today announced the appointment of Andrew S. Wechsler, M.D., as its medical director. Dr. Wechsler will chair...
50 - ZOLL LifeVest Prescribed by Physicians at All 21 U.S. News and World Reports “Honor Roll” Hospitals and All 50 “Best Heart and Heart Surgery” Hospitals
CHELMSFORD, Mass.-(Business Wire)-September 21, 2009 - ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that physicians at all of the 21 “Honor Roll” hospitals and all of the 50 “Best Heart and Heart...
51 - Blood Flow Blockages in the Heart Can Now Be Measured Using St. Jude Medical Wireless Fractional Flow Reserve Technology
ST. PAUL, Minn.-(Business Wire)-September 21, 2009 - St. Jude Medical, Inc. (NYSE: STJ) today announced the first use of the PressureWire™ Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. This...
52 - 2.25 MM CYPHER® Sirolimus-eluting Coronary Stent Approved by FDA
BRIDGEWATER, N.J.-(Business Wire)-September 21, 2009 - Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the...
53 - Medtronic’s Resolute® Drug-Eluting Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term Follow-up
SAN FRANCISCO-(Business Wire)-September 21, 2009 - New clinical data released today at a major meeting of interventional cardiologists show strong and sustained efficacy and safety of the Resolute® Zotarolimus-Eluting Coronary Stent from Medtronic, Inc. (NYSE: MDT) in long-term patient follow-up...
54 - ENDEAVOR® Stent Reduced Risk of Heart Attack/Cardiac Death by 48% at Three Years Compared to Taxus® Stent in Large Study
SAN FRANCISCO-(Business Wire)-September 21, 2009 - Anticipating a change in the practice of interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today that the latest findings from the ENDEAVOR IV clinical trial – a large study comparing two drug-eluting coronary stents head-to-head...
55 - Sloning Closes Growth Financing Round Led by LBBW Venture
PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...
56 - Research and Markets: This Essential Report on Coronary Artery Stenting is Now Available
DUBLIN-(Business Wire)-September 21, 2009 - Research and Markets are common, and found in approximately one third of patients with significant coronary artery disease who undergo angiography. Over the past 20 years, CTO lesions have represented the most difficult anatomy for treatment — with...
57 - Vitae Initiates Phase 1 Trial of Novel Renin Inhibitor
FORT WASHINGTON, Pa.-(Business Wire)-September 21, 2009 - Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its novel cardiovascular agent, VTP-27999. VTP-27999 is a novel, proprietary renin inhibitor...
58 - CardiAQ Valve Technologies (CVT) Elects Rob Michiels as a Director
CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), today announced that it has elected Rob Michiels to serve on its Board of Directors, effective immediately. Until April 2009...
59 - New Zilver PTX Drug-Eluting Stent from Cook Medical Could Greatly Reduce Need for Leg Amputations and Bypass Surgery for European Patients
LISBON-(Business Wire)-September 21, 2009 - In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial...
60 - PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis
BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference in Boston, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of the Columbus™ 2.0 platform, its flagship high content...
61 - Toshiba Introduces Low-Contrast Vascular Imaging
SAN FRANCISCO-(Business Wire)-September 21, 2009 - To continue its commitment to advancing medical imaging technology and improving diagnosis, Toshiba America Medical Systems, Inc. introduces Low-Contrast Imaging (LCI) for Toshiba’s InfinixTM-i systems with mid (12” x 12”) and large (12” x...
62 - Metabasis Therapeutics Receives Notice of Noncompliance with Nasdaq Listing Requirements
SAN DIEGO-(Business Wire)-September 18, 2009 - Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”), notifying the Company that based upon the closing...
63 - Medtronic Expects New Data on Drug-Eluting Stents and Transcatheter Heart Valves to Feature at TCT 2009
MINNEAPOLIS-(Business Wire)-September 18, 2009 - Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its...
64 - AtriCure Announces Investor Conference Schedule
WEST CHESTER, Ohio-(Business Wire)-September 18, 2009 - AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it will participate in the following investor conferences during September and October: The UBS Global Life Sciences...
65 - Positron Joins Exhibitors at MedAxiom Fall Conference to Promote the Attrius, Positron’s Cardiac Optimized PET Scanner
INDIANAPOLIS-(Business Wire)-September 18, 2009 - Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend MedAxiom’s Fall Conference in Dana Point, California September 23rd, 2009 to promote their cardiac optimized PET scanner, the...
66 - Integrative Therapeutics, Inc. Seeking 2010 Residency Sites for STAIR Scholarship Program
GREEN BAY, Wis.-(Business Wire)-September 18, 2009 - Integrative Therapeutics, Inc (ITI®), in collaboration with the American Association of Naturopathic Physicians (AANP), is seeking qualified residency sites for the fourth year of the ITI & AANP STAIRSM Residency Scholarship Program. This...
67 - ZOLL Medical Named One of Fortune Magazine’s 100 Fastest Growing Companies
CHELMSFORD, Mass.-(Business Wire)-September 17, 2009 - ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that Fortune magazine has ranked ZOLL #85 on its list of the 100 fastest growing companies. In an article entitled...
68 - CardiacAssist Partners with Mentice to Showcase Transseptal Puncture Training Simulation at “TCT 2009” Exhibit Booth #2005
PITTSBURGH-(Business Wire)-September 17, 2009 - CardiacAssist Inc. announced today that it will showcase transseptal puncture training simulation, developed by Mentice Inc., at its TandemHeart® System exhibit in San Francisco at the “Transcatheter Therapeutics (TCT) 2009” Annual Scientific...
69 - Hythiam Raises Approximately $7 Million in Registered Direct Offering
LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing...
70 - Coherex Medical Announces Lunch Symposium During TCT 2009 (the Transcatheter Cardiovascular Therapeutics Conference) on Tues., Sept. 22, 2009
SALT LAKE CITY-(Business Wire)-September 17, 2009 - Coherex Medical, Inc. today announced that it will host a lunch symposium titled “In-Tunnel PFO Closure: Treating the Tunnel Using the Coherex FlatStent™ EF PFO Closure System” on Tuesday, September 22, 2009 during TCT 2009 (the Transcatheter...
71 - Research and Markets: Abdominal & Thoracic CT/MR/US: Optimizing Practice Targets the Community Radiologist Involved In Body and Cardiovascular Imaging
DUBLIN-(Business Wire)-September 17, 2009 - Research and Markets to provide continuing medical education for physicians. Credit Designation UCSF designates this educational activity for a maximum of 17.75 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent...
72 - New Essentials Glycemic Health Brand Pasta Launched Using Hi-maize Natural Resistant Starch
BRIDGEWATER, N.J.-(Business Wire)-September 17, 2009 - National Starch Food Innovation today announced the launch of a new Hi-maize-enriched pasta by Racconto, a leading U.S. importer-producer of private label and branded Italian pasta. The all-natural Essentials Glycemic Health pasta line from...
73 - Angeion Corporation to Present at Wall Street Analyst Conference on Sept. 29
ST. PAUL, Minn.-(Business Wire)-September 17, 2009 - Angeion Corporation (NASDAQ: ANGN), today announced that it will be presenting at the Wall Street Analyst Forum Institutional Investor Conference on Tuesday, Sept. 29, 2009, at 10:30 a.m. Eastern Time. The event is being held at the University...
74 - Lantheus Medical Imaging, Inc. Initiates Phase 1 Study Evaluating Safety and Dosimetry of Novel Heart Failure Imaging Agent
N. BILLERICA, Mass.-(Business Wire)-September 17, 2009 - Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging...
75 - California Stem Cell and Stemina Biomarker Discovery Announce Collaboration to Validate Effectiveness of Human Embryonic Stem Cell-Derived Cardiomyocyte Progenitors for Use in Predictive Toxicology
IRVINE, Calif.-(Business Wire)-September 17, 2009 - Collaboration between California Stem Cell, Inc. (CSC) and Stemina Biomarker Discovery on a study using CSC’s 96-well CardioPlateTM containing high purity human embryonic stem cell (hESC)-derived cardiomyocyte progenitor cells, has demonstrated...
76 - Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
FLAGSTAFF, Ariz.-(Business Wire)-September 17, 2009 - W. L. Gore & Associates (Gore) today announced that several physicians recently presented interim data from ongoing GORE PROPATEN® Vascular Graft studies to clinical audiences at the 2009 annual vascular meeting. The conference, the...
77 - Elixir Medical Announces Activities at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference
SUNNYVALE, California-(Business Wire)-September 17, 2009 - Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals announced today that the company’s stent systems will be featured in multiple sessions at the 21st annual...
78 - EBD Group and Defined Health Form an Alliance on Conference Content
CARLSBAD, Calif. & ZURICH, Switzerland & FLORHAM PARK, N.J.-(Business Wire)-September 16, 2009 - EBD Group and Defined Health today announced the formation of an alliance that will help biopharmaceutical firms gain the insights they need to create and execute successful strategy. Under...
79 - Flexible Stenting Solutions, Inc. Receives 510(k) Clearance for FlexStent® Biliary Self Expanding Stent System
EATONTOWN, N.J.-(Business Wire)-September 16, 2009 - Flexible Stenting Solutions Inc. (“FSS”), a leading developer of next generation peripheral arterial and biliary stents, received 510(k) clearance for the FlexStent® Biliary Self Expanding Stent System. The FlexStent® Biliary Self...
80 - Bioheart Inc. Announces Positive Results in the MARVEL Phase II/III Clinical Trial
SUNRISE, Fla.-(Business Wire)-September 16, 2009 - Bioheart, Inc. (OTCBB:BHRT), presented positive efficacy data from part 1 of its Phase II/III clinical trial at the Heart Failure Society of America (HFSA) Meeting in Boston, Massachusetts. Thomas Povsic, MD, Ph.D., Assistant Professor of Medicine...
81 - 2010 National Hearing Conservation Association Conference to “Explore the World of Hearing Loss Prevention”
WESTMINSTER, Colo.-(Business Wire)-September 16, 2009 - The National Hearing Conservation Association [NHCA] announces that its 35th annual conference will be held February 25-27, 2010 at the Rosen Plaza Hotel in Orlando, Florida. Titled “Explore the World of Hearing Loss Prevention,” the...
82 - Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against CardioNet, Inc.
SAN DIEGO-(Business Wire)-September 16, 2009 - Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”) has more information about the firm.
83 - Internationally Acclaimed Inventor, Dean Kamen, to Receive Prestigious BioMed SA Palmaz Award for Innovation in Healthcare and the Biosciences
SAN ANTONIO-(Business Wire)-September 16, 2009 - Internationally renowned inventor, entrepreneur and thought leader, Dean Kamen of Manchester, NH, can add another prestigious award to his resume when he accepts BioMed SA’s Julio Palmaz Award for Innovation in Healthcare and the Biosciences. BioMed...
84 - Alliance Health Networks Closes $3.3 Million Financing Led by Highway 12 Ventures
SALT LAKE CITY-(Business Wire)-September 16, 2009 - Alliance Health Networks, Inc. today announced that it has closed a $3.3 million Series C Preferred Stock financing led by Highway 12 Ventures. EPIC Ventures, Series B lead investor, also participated in the Series C round along with other...
85 - NMT Medical to Accelerate CLOSURE I Data Analysis Timing
BOSTON-(Business Wire)-September 16, 2009 - NMT Medical, Inc. (NASDAQ: NMTI) announced today that, upon recommendation of the CLOSURE I Executive Committee, it will commence data analysis for its landmark patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) clinical trial...
86 - PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets
WALTHAM, Mass.-(Business Wire)-September 16, 2009 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay...
87 - Toshiba Expands Availability of Next Generation Advanced Image Processing for Infinix-i Line
TUSTIN, Calif.-(Business Wire)-September 16, 2009 - Improving the ability to provide premium patient care during interventional procedures, Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba...
88 - Washington State Life Sciences Discovery Fund Awards Health Research Project Grants
SEATTLE-(Business Wire)-September 15, 2009 - Six research project grant awards totaling $5.1 million will be made to Washington life sciences organizations and their partners, the state’s Life Sciences Discovery Fund announced today. The projects are aimed at improving human health and will...
89 - Long Beach Memorial Successfully Implants Cutting-Edge Heart Attack Detection Device
LONG BEACH, Calif.-(Business Wire)-September 15, 2009 - MemorialCare Heart and Vascular Institute at Long Beach Memorial Medical Center (LBMMC) successfully implanted a new, cutting-edge heart attack detection device in two heart attack survivors this morning. With the danger of a second heart...
90 - PPD Opens Global Central Lab in Singapore
WILMINGTON, N.C.-(Business Wire)-September 15, 2009 - PPD, Inc. (Nasdaq: PPDI) today announced it has opened its global central lab facility in Singapore, strengthening its ability to provide biopharmaceutical clients an extensive range of customized laboratory services in Southeast Asia, a...
91 - Medifacts Presents Free Symposium on “Meeting the Evolving Cardiac Safety Requirements from Diabetes to Oncology” at the North Carolina Biotech Center
-(Business Wire)-September 15, 2009 - Medifacts International: Who: Medifacts International, Jeff Heilbraun and Boaz Mendzelevski, MD Title: Recognizing the Cardiac Safety Continuum; Meeting the Evolving Cardiac Safety Requirements for New Medicinal Entities from Diabetes to Oncology...
92 - THE SAGE GROUP Supports the “Stop P.A.D.” Petition Drive to Expand Medicare Coverage to Test Patients for Peripheral Arterial Disease
ATLANTA-(Business Wire)-September 15, 2009 - In recognition of National P.A.D. Awareness Month, Mary L. Yost, President of THE SAGE GROUP recommends that patients, relatives, and the medical community join the campaign to increase access to a simple noninvasive test to diagnose peripheral arterial...
93 - Early Research Shows Cardiac Resynchronization Therapy May Benefit Patients with Ejection Fractions above 35 Percent
MINNEAPOLIS & BOSTON-(Business Wire)-September 15, 2009 - Early findings from a Medtronic, Inc. (NYSE: MDT) sponsored study show heart failure patients with moderate ejection fractions, over 35 percent, may receive comparable benefits from cardiac resynchronization therapy (CRT) as compared to...
94 - Carolinas Medical Center Adopts TandemHeart®— Versatile Circulatory Support Device from CardiacAssist
CHARLOTTE, N.C.& PITTSBURGH-(Business Wire)-September 15, 2009 - CardiacAssist Inc. announced today that Charlotte-based Carolinas Medical Center has adopted the company’s TandemHeart® System. Carolinas Medical Center is in select company: more than 100 of the nation’s elite cardiac...
95 - Campbell Soup Company Teams up with Style Expert Tim Gunn in Search of Red Dress Designs From the Heart, For the Heart
CAMDEN, N.J.-(Business Wire)-September 15, 2009 - Campbell Soup Company (NYSE:CPB) is launching the fourth year of its heartwarming, heart-health campaign with a personal touch — inviting Americans to share their connections to heart disease and channel their inspiration to create the next...
96 - Tryton Celebrates 250th Implant of Innovative Side Branch Stent System
DURHAM, N.C.-(Business Wire)-September 15, 2009 - Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that the company’s Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at a...
97 - SonoSite Highlights New Patient Safety Technology and Other Advances for Vascular Access Applications
BOTHELL, Wash.-(Business Wire)-September 14, 2009 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today new patient safety technology, mobile power solutions and image quality advances for vascular access applications. The...
98 - Positron Corporation Sees Significant Opportunities in Canadian PET Market with Ontario’s Approval of PET
INDIANAPOLIS-(Business Wire)-September 14, 2009 - Positron Corporation (OTCBB:POSC) today announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under...
99 - Research and Markets: Cardiovascular Medicine: Review and Update for the Practitioner for Candidates for the American Board of Internal Medicine's Subspecialty Qualifying Examination
DUBLIN-(Business Wire)-September 14, 2009 - Research and Markets . Key Topics Covered: ATHEROSCLEROSIS, INFLAMMATION, AND DYSLIPIDEMIA CARDIOVASCULAR IMAGING VALVULAR HEART DISEASE ACUTE CORONARY SYNDROMES VENOUS THROMBOEMBOLISM CONGENITAL HEART DISEASE ELECTROPHYSIOLOGY: ATRIA, VENTRICLES, DEVICES...
100 - Exer-Rest Technology Presentation at the 2009 European Society of Cardiology Congress is Highly Effective in Treatment of Patients with Coronary Artery Disease, Angina and Reduced Cardiac Function
MIAMI-(Business Wire)-September 14, 2009 - Marvin A Sackner, M.D., Chief Executive Officer of Non-Invasive Monitoring Systems, Inc. [NIMS] (OTCBB:NIMU) announced that Drs. Miyamoto, Fujita and others from Osaka and Kyoto, Japan presented a paper entitled “Novel treatment with whole body periodic...
101 - Banner Heart Hospital Named First Accredited Heart Failure Institute in Arizona
COLUMBUS, Ohio-(Business Wire)-September 14, 2009 - The Healthcare Accreditation Colloquium announced today that Banner Heart Hospital, in partnership with Tri-City Cardiology, Banner Home Care & Banner Hospice, has been named the first Accredited Heart Failure Institute in Arizona. Recognized...
102 - IMPROVE HF, a Guideline-Focused Performance Improvement Study, Demonstrates Significantly Improved Outpatient Heart Failure Quality of Care
MINNEAPOLIS & BOSTON-(Business Wire)-September 14, 2009 - A process improvement program significantly improved the quality of care on six of seven guideline-recommended care measures in the largest U.S. outpatient heart failure clinical study. Twenty-four month findings from IMPROVE HF, (The...
103 - Medtronic Study Shows Fluid Monitoring More Accurate Than Weight Measures for Heart Failure Patients
MINNEAPOLIS & BOSTON-(Business Wire)-September 14, 2009 - Fluid monitoring with OptiVol® Fluid Status Monitoring is a more accurate predictor of worsening heart failure compared to daily weight monitoring in heart failure patients with implantable devices, according to results released today...
104 - Spacelabs Healthcare Launches Sentinel Cardiology Information Management System with Patient Monitoring Integration in the United States
ISSAQUAH, Wash.-(Business Wire)-September 14, 2009 - Spacelabs Healthcare is pleased to announce the U.S. launch of Sentinel, a sophisticated Cardiology Information Management Systems (CIMS), that will facilitate analysis and reporting while also improving efficiency and eliminating errors. Sentinel...
105 - Corventis Announces Enrollment Completion of Clinical Trial Studying Non-Invasive Multi-Sensor Monitoring for Congestive Heart Failure
BOSTON & SAN JOSE, Calif.-(Business Wire)-September 14, 2009 - Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced today enrollment completion of the company’s MUSIC (Multi-Sensor...
106 - Corventis Announces CE Mark for AVIVO™ Mobile Patient Management System
SAN JOSE, Calif.-(Business Wire)-September 14, 2009 - Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company’s AVIVO™ Mobile Patient Management System...
107 - St. Jude Medical Announces FDA Approval of EnSite Velocity Cardiac Mapping System
ST. PAUL, Minn.-(Business Wire)-September 14, 2009 - St. Jude Medical, Inc. (NYSE: STJ) today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of its EnSite Velocity™ Cardiac Mapping System. This new system has been designed to help physicians more efficiently diagnose...
108 - 2009 Lasker Awards Honor Trailblazers in Medical Research and Public Service:
NEW YORK-(Business Wire)-September 14, 2009 - The Albert and Mary Lasker Foundation, which for 64 years has championed the greatest breakthroughs in medical research, today announced the winners of the 2009 Lasker Awards for outstanding accomplishments in basic medical and clinical medical research...
109 - New Ohio Bioscience Resource Directory Keeps Pace with Industry Sector’s Growth
COLUMBUS, Ohio-(Business Wire)-September 10, 2009 - BioOhio and the Global Cardiovascular Innovation Center (GCIC) have launched an expanded and improved Ohio Bioscience Resource Directory, the most comprehensive online collection of Ohio companies, organizations, and research centers involved in...
110 - Abiomed to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference
DANVERS, Mass.-(Business Wire)-September 10, 2009 - Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Morgan Stanley 2009 Global Healthcare...
111 - 1,500 Clinicians, 55 World-Renowned Clinical Experts, and 21 Medical Societies Convene in Boston for the 4th Annual Cardiometabolic Health Congress
BOSTON-(Business Wire)-September 10, 2009 - The 2009 Cardiometabolic Health Congress (CMHC) will hold its fourth annual meeting October 7–10, 2009, at the Sheraton Boston Hotel. “The current national debate on health care reform and health care cost has begun to focus attention on the issue...
112 - CardioNet Announces Enhanced MCOT System
CONSHOHOCKEN, Pa.-(Business Wire)-September 10, 2009 - CardioNet, Inc. (NASDAQ:BEAT) today announced the availability of new, innovative clinical and reporting enhancements to the Company’s existing Mobile Cardiac Outpatient Telemetry™ (MCOT™) service. These enhancements allow physicians to...
113 - Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015
NEW YORK-(Business Wire)-September 10, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015...
114 - Research and Markets: Canada Cardiovascular Devices Market Analysis and Forecasts to 2015
DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy Understand what the new growth opportunities are within the...
115 - Research and Markets: Australia Cardiovascular Devices Market Analysis and Forecasts to 2015
DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy Understand what the new growth opportunities are within the...
116 - ChinaBio® Day Unveils Program Highlights
CARLSBAD, Calif. & SAN FRANCISCO-(Business Wire)-September 10, 2009 - EBD Group and ChinaBio® LLC, today unveiled program highlights for the ChinaBio® Day event to be held on September 15, 2009 at the San Francisco Marriott. In the heart of the American biotech industry, this unique event will...
117 - Metabasis Therapeutics Receives Notice of Delisting from Nasdaq Capital Market
SAN DIEGO-(Business Wire)-September 9, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the “Staff”) notifying the Company that it did not comply with the minimum...
118 - PolyMedix to Present at Rodman & Renshaw’s 11th Annual Global Healthcare Conference on September 10, 2009
RADNOR, Pa.-(Business Wire)-September 9, 2009 - PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will present at Rodman & Renshaw’s Eleventh...
119 - Research and Markets: Extensive Congestive Heart Failure Therapy Area Pipeline Report with the Latest News and Developments
DUBLIN-(Business Wire)-September 9, 2009 - Research and Markets has announced the addition of the "Congestive Heart Failure Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Congestive Heart Failure Therapy Area Pipeline Report contains detailed information on the...
120 - CardiovascularLIVE.com to Host Mount Sinai Medical Center in New York’s Live Coronary Intervention Series
MALVERN, Pa.-(Business Wire)-September 9, 2009 - CardiovascularLIVE.com, dedicated to advancing education in the field of cardiology, announced today it has entered into an agreement with Mount Sinai Medical Center in New York to host its live coronary intervention series. CardiovascularLIVE.com...
121 - Research and Markets: Stroke Central Nervous System Therapy Area Pipeline Report Provides Detail on the Top 20 Companies with Products in the Early and Late Stage of Development
DUBLIN-(Business Wire)-September 9, 2009 - Research and Markets has announced the addition of the "Stroke_Central Nervous System Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Stroke_Central Nervous System Therapy Area Pipeline Report contains detailed information on...
122 - PPD Names Deborah Covington as Global Head of Observational Studies and Pregnancy Registries
WILMINGTON, N.C.-(Business Wire)-September 9, 2009 - PPD, Inc. (NASDAQ: PPDI) today announced the appointment of Deborah Covington, Dr.PH., as global head of observational studies and pregnancy registries. In this role, she will provide leadership and direction to the company’s late stage group...
123 - CardiacAssist to exhibit and host symposium at "TCT 2009"
CardiacAssist Inc. “For clinicians who wish to treat high-risk cardiac intervention patients with the utmost safety,the TandemHeart system can certainly offer a critically important advantage to their program.” Howard Cohen, M.D., FACC, FSCAI...
124 - Laureate Pharma and Neoprobe Corporation Announce Manufacturing Alliance
DUBLIN, Ohio & PRINCETON, N.J.-(Business Wire)-September 8, 2009 - Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, and Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today...
125 - Abiomed to Showcase Impella® Technology at TCT 2009; Customer Evening Symposium on Tuesday, September 22
DANVERS, Mass.-(Business Wire)-September 8, 2009 - Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced its schedule of events at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific...
126 - Amerinet Named Provider of Choice by National Rural Health Association Partnership
ST. LOUIS-(Business Wire)-September 8, 2009 - In recognition of their commitment to helping rural healthcare providers reduce costs and improve quality, Amerinet, a leading national healthcare group purchasing organization, has been named a “Provider of Choice” by the National Rural Health...
127 - MiCardia® Announces Completion of Enrollment in “DYANA” European CE Study
IRVINE, Calif.-(Business Wire)-September 8, 2009 - MiCardia® (MiCardia® Corporation, Irvine, California) today announced the completion of enrollment in its European “DYANA” (Dynamic Annuloplasty Activation) study, designed to support submission for CE mark of the firm’s Dynaplasty...
128 - American Diversified Holdings Corporation Enters into Broad Strategic Alliance with Leading Biotech Company INVENT Pharmaceuticals, Inc.
DEL MAR, Calif.-(Business Wire)-September 8, 2009 - Ernest B. Remo, Chairman/CEO of American Diversified Holdings Corporation (Pink Sheets: ADHC), announced today that ADHC has entered into a broad strategic alliance with INVENT Pharmaceuticals, Inc. Under the terms of the agreement ADHC will...
129 - Response Biomedical to Present at Rodman & Renshaw Annual Global Investment Conference
VANCOUVER, British Columbia-(Business Wire)-September 8, 2009 - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that S. Wayne Kay, Chief Executive Officer, will present a corporate update at the Rodman & Renshaw 11th Annual Healthcare Conference as part of Rodman and...
130 - Averion Announces Going Private Transaction
SOUTHBOROUGH, Mass.-(Business Wire)-September 4, 2009 - Averion International Corporation (OTC BB: AVRO), today announced that it has filed an information statement with the Securities and Exchange Commission (SEC) regarding its plan to go private. A majority of the Company’s common shareholders...
131 - Angeion Corporation to Exhibit at 2009 European Respiratory Society Congress in Vienna, Austria
SAINT PAUL, Minn.-(Business Wire)-September 3, 2009 - Angeion Corporation (NASDAQ: ANGN) today announced that it will exhibit at the 2009 European Respiratory Society (ERS) Congress in Vienna, Austria, Sept. 12-16. At booth G30 in hall B, Angeion will preview its all-new MedGraphics CPX Express...
132 - nSpire Health Lands $9M in Clinical Research Trials
LONGMONT, Colo.-(Business Wire)-September 3, 2009 - nSpire Health, a leading global manufacturer of respiratory diagnostic products and services, announced today clinical trial research services awards of over $9 million in August. The trials awarded by prominent pharmaceutical companies include the...
133 - Neoprobe to Present at Rodman & Renshaw Conference
DUBLIN, Ohio-(Business Wire)-September 3, 2009 - Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present on Thursday, September 10...
134 - XDx to Present at the Thomas Weisel 2009 Healthcare Conference
BRISBANE, Calif.-(Business Wire)-September 3, 2009 - XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, today announced that Pierre Cassigneul, president and chief executive officer, is scheduled to present at the...
135 - Metabasis Hires Financial Advisor to Evaluate Strategic Alternatives
SAN DIEGO-(Business Wire)-September 3, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that it has hired Merriman Curhan Ford as its financial advisor to assist the Company in exploring and evaluating strategic alternatives. At this time, Metabasis has not made a decision to pursue...
136 - Reportlinker Adds Pacemakers Pipeline, Technology and Market Forecasts to 2015
NEW YORK-(Business Wire)-September 3, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Pacemakers Pipeline, Technology and Market Forecasts to 2015...
137 - Reportlinker Adds Atrial Fibrillation Pipeline, Technology and Market Forecasts to 2015
NEW YORK-(Business Wire)-September 3, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Atrial Fibrillation Pipeline, Technology and Market Forecasts to 2015...
138 - Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
OSAKA, Japan & MARLBOROUGH, Mass.-(Business Wire)-September 3, 2009 - Dainippon Sumitomo Pharma Co., Ltd. (“DSP”, TSE: 4506) and Sepracor Inc. (“Sepracor”, Nasdaq: SEPR) today announced that they have entered into a definitive agreement pursuant to which DSP will acquire Sepracor for...
139 - LifeScience Alley® Eighth Annual Conference & Expo Showcase to Highlight Innovative New Technologies
MINNEAPOLIS-(Business Wire)-September 2, 2009 - LifeScience Alley® announced today that eight life science organizations from around the United States and Canada will be exhibiting cutting-edge technologies at the association’s Annual Conference on Dec. 9 as part of the New Technology Showcase...
140 - Cardiovascular Systems to Present at Two September Investor Conferences
ST. PAUL, Minn.-(Business Wire)-September 2, 2009 - Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device company developing and commercializing innovative, interventional treatment systems for vascular disease, will present at two upcoming health care conferences: the Robert W. Baird Health...
141 - Pennsylvania Cardiology Program Implanting Defibrillators that Slow Heart Failure Progression
LEBANON, Pa.-(Business Wire)-September 2, 2009 - Electrophysiologists Robert Stevenson, MD, and Jeffrey L. Williams, MD, MS, FACC, are safely implanting cardiac resynchronization therapy defibrillators in the Good Samaritan Hospital (GSH) Cardiology (Heart Failure) Program. These advanced...
142 - Cardiola Penetrates European Market with Its Muscular CounterPulsation (MCP)-based m.pulse® system
WINTERTHUR, Switzerland-(Business Wire)-September 2, 2009 - Cardiola AG announced today that it has placed its patented m.pulse® system in 10 hospitals located in Germany and Switzerland, on the heels of the system’s CE-Mark approval. MCP was previously only available in a clinical setting...
143 - Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009
IRVINE, Calif.-(Business Wire)-September 2, 2009 - Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) President and CEO, Mark A. Varney, Ph.D., will present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference taking place September 9 - 11, 2009, at the New York Palace Hotel. Dr. Varney will...
144 - First Post-Trial AbioCor Patient Passes Away
DANVERS, Mass.-(Business Wire)-September 1, 2009 - Abiomed, Inc. (NASDAQ: ABMD), has been informed by Mark Anderson, M.D., associate professor of surgery at UMDNJ-Robert Wood Johnson Medical School and chief of the section of cardiac surgery at both the medical school and Robert Wood Johnson...
145 - TCA Cellular Therapy Presents Adult Stem Cell Findings to European Society of Cardiology Congress
BARCELONA, Spain-(Business Wire)-September 1, 2009 - This week TCA Cellular Therapy`s Medical Director Gabriel Lasala, M.D. presents advances in adult stem cell treatments for severe limb ischemia and refractory coronary ischemia at the European Society of Cardiology Congress in Barcelona, Spain...
146 - Pennsylvania Father Receives Fourth Heart in Five Years
TUCSON, Ariz.-(Business Wire)-September 1, 2009 - Over the last five years, Jim Hennigan has had four different hearts beating in his chest… the heart he was born with, two donor hearts and a Total Artificial Heart. Hennigan received his newest donor heart on May 8, 2009, after living for more...
147 - Multiple Presentations at the European Society of Cardiology Congress Document EECP Promotes Coronary Collateral Flow Leading to Sustained Clinical Improvement
WESTBURY, N.Y.-(Business Wire)-September 1, 2009 - Vasomedical, Inc. (“Vasomedical”) (OTC: VASO), a world leader in the noninvasive treatment of cardiovascular diseases, today announced that evidence presented by Dr. Eva-Elina Buschmann on behalf of the European Arteriogenesis Network 2 Trial...
148 - Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis’ President, CEO & CSO
SAN DIEGO-(Business Wire)-September 1, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that Mark Erion, PhD, the Company’s president, chief executive officer and chief scientific officer as well as a member of its board of directors, has resigned as an officer and director of the...
149 - Endosense Closes USD 36 Million / Euro 25 Million Series B Financing
GENEVA-(Business Wire)-September 1, 2009 - Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de...
150 - ResearchPoint Expands Services with New Resource Management Organization
AUSTIN, Texas-(Business Wire)-September 1, 2009 - ResearchPoint, a leading global CRO providing drug development services to pharmaceutical, biotechnology and device companies, is pleased to announce the formation of a new resource management organization. The affiliate organization...
151 - Novel Biomarkers, Including CRP, Did Not Predict Risk Of Cardiovascular Events In Patients With Heart Disease Who Were Treated With A Statin
BARCELONA, Spain-(Business Wire)-September 1, 2009 - For patients with established heart disease who were treated with a statin, 18 novel biomarkers including C-reactive protein (CRP) did not predict future cardiovascular events such as heart attack and stroke, according to results of an analysis...
152 - CardioNet Provides Update on Communications with Highmark Medicare Services Regarding Mobile Cardiovascular Technology Reimbursement
CONSHOHOCKEN, Pa.-(Business Wire)-August 31, 2009 - CardioNet, Inc. (NASDAQ:BEAT) announced that Highmark Medicare Services (HMS) confirmed it will implement its reduced reimbursement rate for mobile cardiovascular technology on September 1, 2009. The rate - $754 per service – represents a 33...
153 - Law Offices of Howard G. Smith Announces Class Action Lawsuit Against CardioNet, Inc.
BENSALEM, Pa.-(Business Wire)-August 31, 2009 - Law Offices of Howard G. Smith announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased the common stock of CardioNet, Inc. (“CardioNet” or the “Company”) (Nasdaq:BEAT) between April 30...
154 - First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER® Sirolimus-Eluting Coronary Stent
BRIDGEWATER, N.J.-(Business Wire)-August 31, 2009 - Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range...
155 - Promising Results of Drug Trial Could Herald a Replacement for Popular Blood Thinner
WYNNEWOOD, Pa.-(Business Wire)-August 31, 2009 - Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin® (sold generically as Warfarin), taken by millions of Americans to reduce their risk of...
156 - A-Life Medical, Inc. Chief Financial Officer Named CFO of the Year by San Diego Business Journal
SAN DIEGO-(Business Wire)-August 31, 2009 - A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding products and services to the healthcare industry, announced today that Jaye Connolly, who serves as chief financial officer and chief operating officer, has been named CFO...
157 - Promising Results of Drug Trial Could Herald a Replacement for Popular Blood Thinner, Reports Lankenau Cardiologist and Lead U.S. Researcher in Today’s New England Journal of Medicine
WYNNEWOOD, Pa.-(Business Wire)-August 31, 2009 - Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin® (sold generically as Warfarin), currently taken by millions of Americans to reduce their...
158 - Celladon Corporation and Momentum Research Complete Enrollment of MYDICAR® Phase 2 Study of First-in-Human Gene Transfer to Treat Patients with Advanced Heart Failure
SAN DIEGO-(Business Wire)-August 31, 2009 - Celladon Corporation and Momentum Research, Inc. today announced completion of enrollment of the phase 2 double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research is...
159 - New TRUST Trial Data Confirm Clinical Benefits of BIOTRONIK Home Monitoring®
BARCELONA, Spain, & BERLIN-(Business Wire)-August 31, 2009 - BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced that new data from the TRUST (Lumos-T Safely Reduces Routine Office Device...
160 - New REVERSE Analysis Reinforces Improvements Seen in Mild Heart Failure Patients with Cardiac Resynchronization Therapy
MINNEAPOLIS & BARCELONA-(Business Wire)-August 30, 2009 - Cardiac resynchronization therapy (CRT) is a proven therapy indicated for patients with moderate to severe heart failure. Additional 24-month clinical data presented today on the European cohort of 262 patients in the REVERSE...
161 - New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® in Acute Coronary Syndrome Patients Undergoing Angioplasty
PARIS & PRINCETON, N.J.-(Business Wire)-August 30, 2009 - Today, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical trial at the European Society of Cardiology congress in Barcelona. Sanofi-aventis (EURONEXT:SAN) and (NYSE:SNY) and Bristol-Myers Squibb (NYSE:BMY...
162 - Research and Markets: Company Details of the Top 60 Global Manufacturers of Coronary Stents
DUBLIN-(Business Wire)-August 28, 2009 - Research and Markets Distributors The Top 60 Manufacturers Of Coronary Stents Worldwide is ideal for distributors of interventional cardiology products to identify the leading manufacturers with the best products. Note: Most people will be aware of some of...
163 - Stentys appoints Vice President of Sales and Marketing
PRINCETON, N.J. & PARIS-(Business Wire)-August 28, 2009 - Medical device pioneer Stentys, which has designed a new-generation stent platform for treatment of (1) acute myocardial infarction (AMI) and (2) coronary artery bifurcations, announced today that it has appointed interventional...
164 - St. Jude Medical Announces Opening of European Advanced Learning Center For Continuing Physician Education in Heart Disease Therapies
ST. PAUL, Minn.-(Business Wire)-August 28, 2009 - St. Jude Medical, Inc. (NYSE:STJ) today announced the official opening of the St. Jude Medical Advanced Learning Center, in Brussels, Belgium, offering education and training in advanced, evidence-based therapies for physicians who treat heart...
165 - Four Studies Published in The Lancet Show Roflumilast (Daxas®), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations
NEW YORK-(Business Wire)-August 27, 2009 - Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer and Nycomed, a privately owned pharmaceutical company, today announced that results of four phase III trials have been published in the prestigious...
166 - Cardiovascular Systems Signs U.S. Distribution Agreement with Asahi Intecc Co., Ltd.
ST. PAUL, Minn.-(Business Wire)-August 27, 2009 - Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed an exclusive distribution agreement with Asahi Intecc Co., Ltd...
167 - First Human Immunology Challenge Symposium Announced by NIH’s National Heart, Lung and Blood Institute’s (NHLBI) Center for Human Immunology (CHI)
BETHESDA, Md.-(Business Wire)-August 27, 2009 - NIH’s National Heart, Lung and Blood Institute’s CENTER FOR HUMAN IMMUNOLOGY (CHI) announces the first Meeting the Human Immunology Challenge Symposium. This two-day meeting will be held September 3-4, 2009 on the NIH Campus. This symposium is...
168 - Welch Allyn and Inovise Medical Announce Technology Agreement
SKANEATELES FALLS, N.Y.-(Business Wire)-August 27, 2009 - Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the...
169 - PolyMedix and University of Massachusetts Receive $100,000 Contract to Develop Novel Antibacterial Compounds against Drug-Resistant Bacterial Biofilms
RADNOR, Pa.-(Business Wire)-August 27, 2009 - PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, have received a Phase I Small Business...
170 - St. Jude Medical To Present at the Thomas Weisel Partners Healthcare Conference
ST. PAUL, Minn.-(Business Wire)-August 26, 2009 - St. Jude Medical, Inc. (NYSE:STJ) will present at the Thomas Weisel Partners Healthcare Conference on Thursday, September 10, in Boston. John C. Heinmiller, executive vice president and chief financial officer, will address the conference at 3:50...
171 - Angeion Corporation Reports Fiscal 2009 Third-Quarter Results
ST. PAUL, Minn.-(Business Wire)-August 26, 2009 - Angeion Corporation (NASDAQ: ANGN): Highlights Cash increased to $10.6 million, up $919,000 from the second quarter Gross margin for the quarter rises to 54.4% from 51.6% a year ago Operating expense reduced by $110,000 from prior-year third...
172 - Spacelabs Healthcare Expands International Distribution of USCOM Cardiac Output Monitor
ISSAQUAH, Wash.-(Business Wire)-August 26, 2009 - Spacelabs Healthcare today announced the launch of the Ultrasonic Cardiac Output Monitor (USCOM) in several new geographies, including Latin America, Africa, Europe, Australia and Middle East. USCOM’s unique and totally non-invasive method of...
173 - National Quality Forum Endorses IMS Health Measures to Improve Medication Safety and Quality
NORWALK, Conn.-(Business Wire)-August 26, 2009 - IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, has received the endorsement of the National Quality Forum (NQF) for two of its clinical quality indicators for measuring...
174 - Positron Offers Full Line of Products Through Technology Imaging Services (TIS)
INDIANAPOLIS-(Business Wire)-August 25, 2009 - Positron Corporation (OTCBB:POSC) (the “Company”), a molecular imaging solutions company focused on Nuclear Cardiology, announced today that they have executed an Agent Agreement with TIS – Technology Imaging Services. TIS offers a wide range of...
175 - Good Samaritan Hospital Designated as a Blue Distinction Center for Cardiac Care®
LOS ANGELES-(Business Wire)-August 25, 2009 - Good Samaritan Hospital has been designated by Blue Shield of California as a Blue Distinction Center for Cardiac Care. To date, more than 400 facilities nationwide have received a Blue Distinction Center for Cardiac Care designation. Blue Distinction...
176 - Vascular Closure Systems, Inc. Announces Invitation to Attend One of Our Upcoming Pre-Clinical Studies / Company Expects to Receive a Notice of Allowance for an Unpublished Patent Application in the Near Future
PALO ALTO, Calif.-(Business Wire)-August 25, 2009 - Vascular Closure Systems, Inc.: Invitation to Attend One of Our Upcoming Pre-Clinical Studies - FastSeal™ Bioabsorbable Vascular Access Closure System Several medical device companies (including the market leaders) have recently been invited to...
177 - TomTec Extends the CardioArena™ Product Portfolio with a Vascular Analysis Solution
BARCELONA, Spain-(Business Wire)-August 25, 2009 - TomTec launches the vascular analysis solution M’Ath®1 (Measure of Atherosclerosis) as a further part of TomTec’s CardioArena™ multimodality imaging program at the European Society of Cardiology congress 2009 in Barcelona. The condition of...
178 - Medtronic Reports First Quarter Revenue of $3.9 Billion
MINNEAPOLIS-(Business Wire)-August 25, 2009 - Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009. The company reported first quarter revenue of $3.933 billion, a 6 percent increase compared to the $3.706 billion...
179 - Toshiba Installs Milestone 800th Vantage MR System at Elkview General Hospital
TUSTIN, Calif.-(Business Wire)-August 25, 2009 - Toshiba America Medical Systems, Inc., an industry leader in magnetic resonance (MR) technology, reached a significant achievement in installing its 800th Vantage™ 1.5T MR system at Elkview General Hospital in Hobart, Okla. Elkview is using the...
180 - GE Healthcare and TomTec Imaging Systems Announce Strategic Cooperation in Cardiology IT
MUNICH-(Business Wire)-August 25, 2009 - GE Healthcare, a division of General Electric Company (NYSE:GE) and TomTec Imaging Systems GmbH, a worldwide leader in 2D/3D/4D imaging and quantification technologies, have entered into a formal strategic cooperation contract to boost their excellence in...
181 - Tripep’s RAS Technology and the German Biotech Company Cosmix’ mRNA Display Technology Will Be Co-Developed in the New US Company, Opsonics Therapeutics Inc.
STOCKHOLM, Sweden-(Business Wire)-August 25, 2009 - Tripep (STO:TPEP) and the German biotech company Cosmix AG have both licensed their respective technologies (RAS and mRNA Display Library) to a newly formed US company named Opsonic Therapeuticals Inc. within which Tripep’s RAS technology will be...
182 - ZOLL Receives FDA Approval to Market New LifeVest Model
CHELMSFORD, Mass.-(Business Wire)-August 24, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received approval from the U.S. Food and Drug Administration (FDA) to market and sell a new model of the LifeVest® wearable...
183 - Franklin & Seidelmann Hires Healthcare Executive Larsen to Head New Marketing Initiative
CLEVELAND-(Business Wire)-August 24, 2009 - Franklin & Seidelmann (F&S), a leading, national full-service radiology interpretations provider, today announced that it has added Clayton T. Larsen, an executive from the healthcare equipment, software and services field to lead its new marketing...
184 - Fresenius Medical Care Gives Dialysis Patients Freedom To Travel This Fall and Winter
WALTHAM, Mass.-(Business Wire)-August 24, 2009 - As thousands of people plan getaways for the fall and winter travel seasons, easy access to healthcare is a concern for many travelers with chronic health conditions who require life-sustaining treatments. Twenty-six million Americans suffer from...
185 - Akron General Selects ProVation Software for Cardiology Procedure Documentation and Coding
MINNEAPOLIS-(Business Wire)-February 17, 2009 - Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Akron General Medical Center has selected ProVation MD software for cardiology procedure documentation and coding. The...
186 - Bard Receives FDA Approval for the LifeStent® Vascular Stent
MURRAY HILL, N.J.-(Business Wire)-February 17, 2009 - C. R. Bard, Inc., (NYSE: BCR) today announced that it has received Pre-Market Approval (PMA) from the United States Food and Drug Administration to market the LifeStent® FlexStar and FlexStar XL Vascular Stent Systems. The devices are approved...
187 - California Hospital Implements ZOLL AutoPulse
CHELMSFORD, Mass.-(Business Wire)-February 17, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that Providence Little Company of Mary Medical Center San Pedro in southern California has installed the...
188 - Heart Awareness Evening Scheduled for February 26 at Apple Valley Medical Center
APPLE VALLEY, Minn.-(Business Wire)-February 16, 2009 - A free Heart Awareness community event will be held from 5:00 pm to 7:30 pm on Thursday, February 26, 2009, at the Apple Valley Medical Center. “Heart disease is the leading cause of death for men and women in the United States,” said Scott...
189 - Peer Portner, Pioneer in Heart Pump Surgery at Stanford, Dies at 68
STANFORD, Calif.-(Business Wire)-February 13, 2009 - Peer Portner, PhD, pioneer of the first implanted electric heart assist pump for patients with terminal heart failure, died Monday, Feb. 9, from cancer. He was 68 years old. Internationally known for his life-long work in developing mechanical...
190 - BIO-Europe Spring® 2009 Announces Program Highlights
CARLSBAD, Calif., ZURICH & MILAN-(Business Wire)-February 13, 2009 - EBD Group announced today that the third annual BIO-Europe Spring® partnering event, March 16–18, 2009 at the Milano Convention Centre (MIC), Milan, Italy, will host many of the biggest names in biotech. Featured on panels...
191 - Father of World’s Only FDA & CE Approved Total Artificial Heart Dies at 97
PHILADELPHIA-(Business Wire)-February 12, 2009 - On Feb. 11, Dr. Willem Johan Kolff, the world’s most prolific inventor of artificial organs, passed away at the age of 97 in Philadelphia. Among Dr. Kolff’s many accomplishments were the artificial kidney, heart-lung machine, artificial eye...
192 - Healthcare Accreditation Colloquium Names Indianapolis Hospital First Heart Failure Institute in State
COLUMBUS, Ohio-(Business Wire)-February 12, 2009 - The Healthcare Accreditation Colloquium announced today that Methodist Hospital in Indianapolis has been named the first accredited heart failure institute in the state of Indiana. Only three other hospitals in the nation have earned this...
193 - Take Your Health to Heart This Month, Honoring February as American Heart Health Month
CHATSWORTH, Calif.-(Business Wire)-February 12, 2009 - It is well known that cardiovascular disease (CVD), which affects the heart and arteries and sets a person up for heart attacks and strokes, is the nation’s leading cause of death for adults.* According to recent American Heart Association...
194 - Exactech, Inc. Announces Year End Earnings and Conference Call
GAINESVILLE, Fla.-(Business Wire)-February 12, 2009 - Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its fourth quarter and 2008 year-end earnings on Wednesday, February 18, 2009, after...
195 - Campbell Soup Company Teams up with Actress Jane Krakowski and Fashion Designer Nicole Miller to Help Fight Heart Disease
CAMDEN, N.J.-(Business Wire)-February 12, 2009 - Campbell Soup Company (NYSE:CPB) took the fight against heart disease to the red carpet with fashion, food and entertainment playing leading roles. Television, film and Broadway star Jane Krakowski of NBC’s “30 Rock” and celebrated runway...
196 - Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19
COLORADO SPRINGS, Colo.-(Business Wire)-February 12, 2009 - Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2008 fourth quarter and full year financial results prior to market open on Thursday, February 19, 2009. Company management will host an...
197 - Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
COLUMBIA, Md.-(Business Wire)-February 12, 2009 - Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced the final two-year results for the Company's trial evaluating Prochymal® for the treatment of acute myocardial infarction. Prochymal is a proprietary formulation of adult stem cells designed...
198 - Research and Markets: Cardiac Mapping, 3rd Edition - Latest Achievements and Breakthroughs in the Field of Interventional Electrophysiology and Imaging Technologies
DUBLIN-(Business Wire)-February 11, 2009 - Research and Markets in Different Subset of Ventricular Tachycardias 29. Endocardial Catheter Pace Mapping of Ventricular Tachycardias 30. Electrical and Anatomical Mapping of Different Pathologies: Ischemic, Dilated, and Hypertrophic Cardiomyopathies...
199 - Oscient Pharmaceuticals Restructures Commercial Organization
WALTHAM, Mass.-(Business Wire)-February 11, 2009 - Oscient Pharmaceuticals Corporation (NASDAQ: OSCI) today announced a strategic realignment of its commercial organization to more aggressively preserve the Company’s financial resources, while retaining coverage of those physicians with...
200 - Cardiovascular Systems Reports Fiscal Second-Quarter 2009 Financial Results
ST. PAUL, Minn.-(Business Wire)-February 11, 2009 - Cardiovascular Systems Inc. (CSI): Second-quarter revenue increases to $14.0 million in fiscal 2009 from $4.6 million in fiscal 2008; Current quarter gross margin rises to 70 percent from 53 percent in 2008; Merger expected to close on or about...
Search Our News Using Google Search
Can't find what you want? Try using Google:
